Authors

• A. Alimonti
• Sara Merler (ORCID: https://orcid.org/0000-0002-8691-6284)
• A. Morlacco
• Francesca Galuppini (ORCID: https://orcid.org/0000-0002-3245-2322)
• Viola Moscarda
• Filippo Carletti (ORCID: https://orcid.org/0009-0008-1848-584X)
• Mirko Minini (ORCID: https://orcid.org/0000-0001-9780-4643)
• Daniele Minardi (ORCID: https://orcid.org/0000-0002-9141-4959)
• Bianca Calì (ORCID: https://orcid.org/0000-0002-9090-9992)
• F. Dal Moro
• Sara Zumerle (ORCID: https://orcid.org/0000-0001-6980-0629)
• G. Randazzo
• M. Milella
• Matteo Fassan (ORCID: https://orcid.org/0000-0001-6515-5482)
• G. Reitano
• S. Gillessen
• Daniele Braga (ORCID: https://orcid.org/0000-0003-2168-8425)
• Andrea Zivi

Institutions

• University of Verona (IT)
• University of Padua (IT)
• Azienda Ospedaliera Universitaria Integrata Verona (IT)
• Institute of Oncology Research (CH)
• Istituto Oncologico Veneto (IT)
• Ospedale Regionale di Bellinzona e Valli (CH)
• Azienda Ospedale - Università Padova (IT)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)

Publication Details

Journal

Immuno-Oncology Technology

Published

2024-12-01

DOI

https://doi.org/10.1016/j.iotech.2024.100921

Primary Topic

Prostate Cancer Treatment and Research

Type

article

Field-Weighted Citation Impact

0.00